GPCR modulation by RAMPS

被引:195
作者
Hay, DL
Poyner, DR
Sexton, PM
机构
[1] Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Carlton, Vic 3053, Australia
[2] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
[3] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand
基金
英国生物技术与生命科学研究理事会;
关键词
calcitonin receptor; CL receptor; family B GPCR; GPCR; RAMP; VPAC1; receptor;
D O I
10.1016/j.pharmthera.2005.06.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Our conceptual understanding of the molecular architecture of G-protein coupled receptors (GPCRs) has transformed over the last decade. Once considered as largely independent functional units (aside from their interaction with the G-protein itself), it is now clear that a single GPCR is but part of a multifaceted signaling complex, each component providing an additional layer of sophistication. Receptor activity-modifying proteins (RAMPs) provide a notable example of proteins that interact with GPCRs to modify their function. They act as pharmacological switches, modifying GPCR pharmacology for a particular subset of receptors. However, there is accumulating evidence that these ubiquitous proteins have a broader role, regulating signaling and receptor trafficking. This article aims to provide the reader with a comprehensive appraisal of RAMP literature and perhaps some insight into the impact that their discovery has had on those who study GPCRs. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:173 / 197
页数:25
相关论文
共 137 条
[21]   Novel receptor partners and function of receptor activity-modifying proteins [J].
Christopoulos, A ;
Christopoulos, G ;
Morfis, M ;
Udawela, M ;
Laburthe, M ;
Couvineau, A ;
Kuwasako, K ;
Tilakaratne, N ;
Sexton, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :3293-3297
[22]   Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product [J].
Christopoulos, G ;
Perry, KJ ;
Morfis, M ;
Tilakaratne, N ;
Gao, YY ;
Fraser, NJ ;
Main, MJ ;
Foord, SM ;
Sexton, PM .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :235-242
[23]  
Coast GM, 2001, J EXP BIOL, V204, P1795
[24]   Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure [J].
Cueille, C ;
Pidoux, E ;
de Vernejoul, MC ;
Ventura-Clapier, R ;
Garel, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 294 (02) :340-346
[25]   Genomic structure and chromosome mapping of human and mouse RAMP genes [J].
Derst, C ;
Engel, H ;
Grzeschik, KH ;
Daut, J .
CYTOGENETICS AND CELL GENETICS, 2000, 90 (1-2) :115-118
[26]  
Ding WQ, 2002, CANCER RES, V62, P5223
[27]   Evidence for decreased calcitonin gene-related peptide (CGRP) receptors and compromised responsiveness to CGRP of fetoplacental vessels in preeclamptic pregnancies [J].
Dong, YL ;
Green, KE ;
Vegiragu, S ;
Hankins, GDV ;
Martin, E ;
Chauhan, M ;
Thota, C ;
Yallampalli, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :2336-2343
[28]   Expression of calcitonin gene-related peptide receptor components, calcitonin receptor-like receptor and receptor activity modifying protein 1, in the rat placenta during pregnancy and their cellular localization [J].
Dong, YL ;
Vegiraju, S ;
Chauhan, M ;
Yallampalli, C .
MOLECULAR HUMAN REPRODUCTION, 2003, 9 (08) :481-490
[29]   Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist [J].
Doods, H ;
Hallermayer, G ;
Wu, DM ;
Entzeroth, M ;
Rudolf, K ;
Engel, W ;
Eberlein, W .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (03) :420-423
[30]   Molecular and physiological characterization of an invertebrate homologue of a calcitonin-related receptor [J].
Dubos, MP ;
Badariotti, F ;
Rodet, F ;
Lelong, C ;
Favrel, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 310 (03) :972-978